These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9641459)

  • 1. Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: a prospective paired cohort study.
    Ho GH; Ji CY; Phang BH; Lee KO; Soo KC; Ng EH
    Ann Surg Oncol; 1998 Jun; 5(4):361-7. PubMed ID: 9641459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of insulin-like growth factor and its binding protein mRNA in the endometrium of postmenopausal patients with breast cancer receiving tamoxifen.
    Laatikainen TJ; Tomás EI; Voutilainen RJ
    Cancer; 1995 Oct; 76(8):1406-10. PubMed ID: 8620415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients.
    Ng EH; Ji CY; Tan PH; Lin V; Soo KC; Lee KO
    Ann Surg Oncol; 1998 Mar; 5(2):194-201. PubMed ID: 9527274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF status is altered by tamoxifen in patients with breast cancer.
    Campbell MJ; Woodside JV; Secker-Walker J; Titcomb A; Leathem AJ
    Mol Pathol; 2001 Oct; 54(5):307-10. PubMed ID: 11577172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients.
    Grønbaek H; Tanos V; Meirow D; Peretz T; Raz I; Flyvbjerg A
    Anticancer Res; 2003; 23(3C):2815-20. PubMed ID: 12926118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
    Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G
    Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen.
    Lahti EI; Knip M; Laatikainen TJ
    Cancer; 1994 Jul; 74(2):618-24. PubMed ID: 7518340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I (IGF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status.
    Favoni RE; de Cupis A; Perrotta A; Sforzini S; Amoroso D; Pensa F; Miglietta L
    J Cancer Res Clin Oncol; 1995; 121(11):674-82. PubMed ID: 7593132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, Pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients.
    Helle SI; Anker GB; Tally M; Hall K; Lønning PE
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):167-71. PubMed ID: 8645625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H; Flyvbjerg A; Mellemkjaer L; Tjønneland A; Christensen J; Sørensen HT; Overvad K
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy.
    Helle SI; Mietlowski W; Guastalla JP; Szakolczai I; Bajetta E; Sommer H; Baltali E; Pinter T; Csepreghy M; Ottestad L; Boni C; Bryce C; Klijn JG; Lønning PE
    Eur J Cancer; 2005 Mar; 41(5):694-701. PubMed ID: 15763644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer.
    Corsello SM; Rota CA; Putignano P; Della Casa S; Barnabei A; Migneco MG; Vangeli V; Barini A; Mandalà M; Barone C; Barbarino A
    Eur J Endocrinol; 1998 Sep; 139(3):309-13. PubMed ID: 9758441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
    Pritchard KI; Shepherd LE; Chapman JA; Norris BD; Cantin J; Goss PE; Dent SF; Walde D; Vandenberg TA; Findlay B; O'Reilly SE; Wilson CF; Han L; Piura E; Whelan TJ; Pollak MN
    J Clin Oncol; 2011 Oct; 29(29):3869-76. PubMed ID: 21911723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
    Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
    Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer.
    Frost VJ; Helle SI; Lønning PE; van der Stappen JW; Holly JM
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2216-21. PubMed ID: 8964854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of treatment with onapristone on the IGF-system in breast cancer patients.
    Helle SI; Jonat W; Giurescu M; Ekse D; Holly JM; Lønning PE
    J Steroid Biochem Mol Biol; 1998 Aug; 66(3):159-63. PubMed ID: 9719450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone treatment on serum levels of insulin-like growth factors (IGFs) and IGF binding proteins 1-4 in postmenopausal women.
    Kassem M; Brixen K; Mosekilde L; Blum WF; Flyvbjerg A
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):747-56. PubMed ID: 10209562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factors and their binding proteins in patients with hepatic failure and after liver transplantation.
    Schalch DS; Kalayoglu M; Pirsch JD; Yang H; Raslich M; Rajpal S
    Metabolism; 1998 Feb; 47(2):200-6. PubMed ID: 9472971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer.
    Helle SI; Geisler J; Anker GB; Leirvaag B; Holly JM; Lønning PE
    Br J Cancer; 2001 Jul; 85(2):147-51. PubMed ID: 11461068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.